Now I have all the evidence needed. Let me compile the final consolidated review.

## Summary

CBGBench is a comprehensive benchmark for structure-based drug design (SBDD) that unifies the task as a 3D binding-graph completion problem ("fill-in-the-blank"). It categorizes 12 methods into a systematic taxonomy (voxelized vs. continuous, one-shot vs. autoregressive, domain-knowledge vs. data-driven), modularizes them into a unified codebase with standardized backbones, and extends evaluation to four lead optimization tasks (linker, fragment, side chain, and scaffold design) beyond standard *de novo* generation. The benchmark evaluates across four aspects — substructure, chemical properties, interaction (including PLIP-based interaction patterns and ligand binding efficacy), and geometry (including clash ratios) — and surfaces several empirical insights about method performance.

## Strengths

- **Systematic taxonomy of SBDD methods into three dichotomies**: The paper provides the first unified classification of 12 methods by (i) voxelized vs. continuous position generation, (ii) one-shot vs. autoregressive generation, and (iii) domain-knowledge-based vs. full-data-driven generation (Table 1, Figure 2). This taxonomy enables modular framework design and principled comparison that prior fragmented evaluations could not support.

- **Extension to four practically relevant lead optimization tasks**: CBGBench introduces target-aware linker, fragment, side chain, and scaffold design tasks with explicit molecule decomposition rules and dataset splits derived from Crossdocked2020 (Table 2). The full results across these tasks (Table 7) go substantially beyond the single *de novo* task used in all prior SBDD benchmarks and generate useful observations (e.g., scaffold hopping is the most challenging, linker design the easiest).

- **Comprehensive evaluation protocol with novel metrics**: The benchmark adds interaction pattern analysis via PLIP (per-pocket and overall JSD/MAE, Section 4), ligand binding efficacy (LBE) to normalize Vina energy by atom count, and cross-atom clash ratios (Ratio\_cca/cm). These fill genuine gaps in prior evaluation protocols and surface method-specific behaviors (e.g., CNN-based methods excel in interaction, diffusion models lead in geometry).

- **Comprehensive 12-method comparison with per-aspect and overall rankings**: The paper provides per-aspect rankings (substructure, chemistry, interaction, geometry) and a weighted composite rank (Table 6), enabling clear identification of which methods excel in which dimension — e.g., MolCraft leads overall, LiGAN and VoxBind dominate in interaction.

- **Real-world case study on pharmaceutic targets**: The paper applies pretrained models to two GPCR targets (ADRB1, DRD3) and compares generated molecules with known actives using t-SNE visualization and binding affinity distributions (Figures 6, 7). This provides a qualitative sanity check of whether benchmark findings transfer to real drug targets — a step that most SBDD benchmarks do not take.

## Weaknesses

### Fatal
None.

### Major

1. **Architecture standardization conflates what is being compared (line 153).** The paper standardizes all autoregressive methods to use GVP and all diffusion-based methods to use EGNN+GAT as message-passing modules: *"To eliminate the effect brought about by the architecture of GNNs, in implementation, we use GVP and EGNN with GAT, as message-passing modules of auto-regressive and diffusion-based models, respectively."* While the stated goal — fixing architectures to keep expressivity equal — is reasonable, this choice fundamentally changes what the comparison measures. The benchmark is no longer comparing methods *as originally proposed* (e.g., GraphBP's original flow architecture, Pocket2Mol's original GNN design); it compares generative strategies (autoregressive flow vs. diffusion vs. one-shot) under common GNN backbones. This directly affects how conclusions should be interpreted. For example, the finding that *"the current incorporation of physicochemical priors can hardly improve quality"* (line 247) is based on DecompDiff and D3FG underperforming relative to TargetDiff/MolCraft under the EGNN backbone — but the backbone may be a poor fit for the domain-knowledge mechanisms these methods were designed with. The paper is transparent about the standardization choice but **does not discuss how it limits the interpretability of rankings** anywhere, including in the limitations section (lines 384-387). This is not a fatal flaw (the comparison of generative strategies under controlled backbones is itself informative), but the presentation implies head-to-head comparability that the implementation does not fully deliver.

2. **The claim of "strong consistency and generalizability on real-world target data" (line 377) is not supported by the evidence presented.** The real-world case study evaluates only two targets (ADRB1, DRD3), only 8 of 12 methods, and relies entirely on qualitative evidence: visual inspection of t-SNE plots and Vina energy distributions. No quantitative rank correlation (e.g., Spearman's ρ between benchmark rankings and real-target rankings) is computed. The paper's own phrasing — *"essentially consistent with the conclusion"* — is too strong for the level of evidence provided.

### Minor

3. **Interaction pattern metric conflates distributional similarity with quality (Section 4, line 141).** The metric compares the per-pocket and overall JSD/MAE of interaction-type distributions (from PLIP) between generated molecules and the reference crystal structure. It is presented as measuring whether models *"learn the microscopic interaction patterns"* — but a generated molecule that binds tightly via a different interaction profile than the native ligand is not necessarily deficient. This tension is empirically visible: FLAG and D3FG achieve the best JSD\_OA and MAE\_OA scores respectively while having poor Vina docking scores (FLAG: -3.65, D3FG: -6.78 with low IMP%), showing that reproducing reference interaction patterns does not correlate with binding quality. The metric is useful as a descriptive measure of *distributional similarity to training data* but should not be conflated with interaction quality. The paper does not discuss this disconnect.

4. **No variance or statistical significance measures reported for any metric.** All values in all tables are point estimates (means over the test set). Given that many metrics are close across methods (e.g., QED values of 0.48–0.49 for all diffusion methods), it is impossible to assess whether the observed differences are meaningful or reproducible. The Friedman ranking partially mitigates this by comparing relative ranks, but without variance information the ranks themselves may be unstable. This is a standard expectation for benchmark papers.

5. **Missing diversity and novelty metrics.** The benchmark evaluates chemical properties (QED, SA, LogP, LPSK) and substructure distributions, but does not assess whether generated molecules are novel or diverse (e.g., internal diversity, nearest-neighbor Tanimoto similarity to the training set). A method that reproduces training-set molecules could score well on the current metrics but would be useless for *de novo* generation. This is a gap for a generative modeling benchmark.

6. **Small test sets for lead optimization tasks (Table 2).** The four subtasks have test sets of only 43 (linker), 61 (fragment), 64 (side chain), and 64 (scaffold) molecules. While the decomposition is reasonable, conclusions about generalization on these tasks should be stated more cautiously. The paper does not discuss whether these small sets are sufficient for reliable ranking.

7. **Only 6 of 12 methods are evaluated on the lead optimization subtasks, and the selection systematically excludes domain-knowledge and voxelized methods** (Section 5.2, line 252). The paper acknowledges this as a limitation but readers should be aware that the "extensibility" claim is demonstrated on a restricted subset.

### Trivial
None.

## Nice-to-Haves

- **Quantify backbone impact**: An ablation showing how rankings change when all methods use a single backbone (e.g., all EGNN or all GVP) — or showing results with original architectures where feasible — would transform the architecture standardization concern into a methodological strength.
- **Add runtime/compute cost comparison**: For a benchmark, reporting GPU-hours or wall-clock time per method would help practitioners weigh quality vs. cost.
- **Verify train/test separation for subtasks**: Since the subtask datasets are derived by decomposing molecules from Crossdocked2020, confirming that no test molecule's full structure appears in the training set of any task would rule out leakage concerns.
- **Provide quantitative rank correlation for the real-world case study**: Computing Spearman's ρ between Crossdocked rankings and GPCR-target rankings would directly support or refute the generalizability claim.
- **Discuss the weighting scheme**: The overall ranking weights (0.2 substructure, 0.2 chemical, 0.4 interaction, 0.2 geometry, line 288) are not justified; interaction is weighted double without explanation. Reporting per-aspect ranks separately (which the paper already provides in Table 6) is the better approach, and the weighted rank could be de-emphasized or its sensitivity tested.

## Removed Points

- *"The interaction pattern metric penalizes legitimate diversity"* (Harsh Critic Issue 2, first half) — The metric compares aggregate distributions across many molecules, not individual molecule matching. A model generating diverse binding modes could still match the reference distribution at the aggregate level. The valid concern is about conflating similarity with quality (kept as Minor #3 above), not about penalizing diversity per se.
- *"The weighting of LBE vs. raw Vina score in the ranking is not transparent"* — The paper's LogP ranking rule (rank 1 if in range, rank 2 if outside) is a reasonable heuristic. Per-metric ranks are shown.
- *"The task definitions are not validated against medicinal chemistry practice"* — The paper cites relevant literature (Bemis-Murko decomposition, FBDD linker criteria, etc.) for its task definitions. Full validation against expert practice, while desirable, goes beyond the normal scope of a computational benchmark paper. Moved to Nice-to-Have.
- *"Hyperparameter sensitivity: default configs may be suboptimal"* — The paper uses default hyperparameters as stated, which is standard practice in benchmarks. Retuning all methods would be a much larger undertaking and is not expected. Moved to Nice-to-Have.
- *"Should present results under both standardized and original architectures"* — This is a constructive suggestion, not a weakness of the current paper. Moved to Nice-to-Have.

## Novel Insights

The reviews surface a central tension that the paper does not fully confront: **the same architecture standardization that enables controlled comparison of generative strategies also prevents the benchmark from being a direct comparison of published methods.** The paper's strongest conclusions — particularly that "domain knowledge integration does not clearly help" — are the most vulnerable to this issue, because methods with specialized prior mechanisms (DecompDiff, D3FG) are forced into a generic EGNN backbone that may not adequately support their intended design. A more honest framing would restructure the paper around the claim "comparison of generative strategies under common GNN backbones" rather than "comparison of published methods as proposed." The benchmark remains valuable regardless — what it measures is different from what its framing implies.

## Suggestions

1. **Reframe the architecture standardization explicitly in the paper**: State clearly that the comparison is between *generative strategies under standardized backbones*, not between methods *as originally published*. Add an ablation in the appendix (or main text if space allows) showing how rankings shift under alternative backbone assignments to quantify sensitivity.

2. **Add a caveat to the interaction pattern metric**: Reframe it as measuring "distributional similarity of interaction types to the training data" rather than "interaction quality." Add a brief discussion of the disconnect between pattern-matching scores and binding affinity shown in the tables.

3. **Add variance information**: Report standard deviations or bootstrapped confidence intervals for at least the top-level metrics (Vina Dock, QED, JSD_BL). This is a minimal addition that would substantially strengthen the benchmark's reliability claims.

4. **Tone down the real-world generalizability claim**: Replace "strong consistency and generalizability" with a more measured statement, and add a quantitative rank correlation (even simple Spearman's ρ) between the Crossdocked and GPCR-target rankings.

## Score and Decision

**Score**: 6.5 — A solid, ambitious benchmark with genuine contributions (unified taxonomy, lead optimization tasks, comprehensive metrics) that would benefit from reframing the architecture standardization caveat and strengthening several empirical claims. The core contributions are valuable and the paper is well-motivated.

**Decision**: Accept — The paper makes a clear contribution to the field that outweighs its presentational shortcomings, which are addressable in a final version.

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <decision>Accept</decision>